Oura valued at $5B following deal with medical device firm Dexcom
Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom.
Le Lézard56m
Boehringer's focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has been lifted to 8th place in the 2024 Access to Medicine Index (ATMI), up from 13th in 2022. This improvement reflects the ...